Stability Testing and Forced Degradation Studies for Pharmaceuticals

Keep your pharmaceutical development on track with integrated stability storage and testing in FDA-registered and inspected facilities, where samples remain under ICH-compliant environmental monitoring from storage through analysis. Generate stability-indicating data for regulatory submissions, supported by specialized storage conditions, validated analytical methods, and comprehensive testing capabilities across Element’s North American laboratories.

Stability testing pharmaceuticals and biologics
I'm trying to...

What is Stability Testing and Forced Degradation Studies for Pharmaceuticals at Element?

Stability testing evaluates pharmaceutical product quality over time under varying environmental conditions. Forced degradation studies provide a valuable tool to evaluate drug substance stability and understand its potential impact on potency, purity, and patient safety. The impurity profile of an API or drug substance stressed under various conditions informs analytical method development, product packaging, shipping, aids in defining specifications, and assists in formulating stable dosage forms.

Element's comprehensive analytical services track product performance, identifying critical quality attributes and potential degradation pathways throughout the entire development lifecycle. Our stability storage and testing programs provide robust data you need to support your CMC strategy and regulatory submission, ensuring consistent product quality from early development through commercialization.

Element life sciences testing expert in lab

What Can Element Offer You For Stability Testing and Forced Degradation Studies?

Products and materials we test

Element provides comprehensive stability testing that addresses pharmaceutical product development challenges across the entire lifecycle, from preclinical stages through clinical trials and post-approval studies. Our analytical experts deliver robust testing programs that generate high-quality data to support development milestones while meeting regulatory requirements, covering pharmaceutical drug substances and products, various dosage forms, including oral solids, parenterals, and topical products.

Key tests offered

Element's scientists create stability programs for drug substances and products, covering impurities, degradants, and changes in physicochemical properties like dissolution and disintegration of solid-dose products alongside rheology of topical formulations. Our stability chambers offer 24/7 monitoring with backup generators to ensure continuous testing and redundancy on critical systems supporting various storage conditions, including cGMP-compliant environments for commercial stability studies and expiration dating.
 
Pharmaceutical Stability Testing:
  • ICH stability testing services across standard conditions
  • Real-time and long-term stability under controlled conditions
  • Accelerated stability programs
  • In-use studies and beyond-use stability
  • Photostability testing to ICH guidelines
  • Formulation evaluation stability
  • Follow-up stability testing
  • Freeze-thaw stability studies
  • Stability-indicating assay development
  • Stress stability testing
  • R&D stability testing
  • Identification of unknown degradants and impurities
  • Registration batch stability testing
  • Finished product release
  • Sterility and microbiological assessment
  • Container-closure integrity testing

 

Forced Degradation Studies:
Element follows ICH drug stability guidelines, which involve stress studies on drug molecules to determine intrinsic stability characteristics and allow for identification of degradation products. Our experts support stress studies through robust analytical procedures to determine molecule stability and help you select proper formulation and package, provide suitable storage conditions and shelf life for your drug products and drug substances.
 
Our forced degradation services include:
  • Protocol design for degradation studies defined by leading chemists
  • Identification of degradation products using advanced analytical techniques
  • Proven track record developing stability-indicating assays based on degradation data
  • Comprehensive reports 

 

Photostability Testing:
Photostability testing evaluates how light exposure affects drug substances and drug products, identifying photodegradation pathways that might occur during manufacturing, storage, or patient use. Light-induced degradation differs from thermal or oxidative pathways, often producing unique degradants through different chemical mechanisms that require specific analytical detection.
 
Element conducts photostability studies under controlled light exposure conditions defined by ICH. Understanding photostability behavior informs packaging decisions such as amber glass selection, opaque secondary packaging requirements, or label warnings about light protection, ensuring product quality remains stable under the light exposure conditions products might encounter throughout their lifecycle, from manufacturing through patient administration.
 
Element delivers advanced analytical solutions that meet complex regulatory requirements, including detailed testing programs designed to generate specific data needed for your product. Our comprehensive approach addresses your product's unique characteristics through development of stability-indicating analytical methods, identification of unknown degradants and impurities, and specialized analytical techniques for precise product characterization.
 
Analytical Capabilities:
  • Development of stability-indicating analytical methods
  • Identification of unknown degradants and impurities
  • Specialized analytical techniques for precise product characterization
  • Comprehensive quality attribute evaluation
  • Support for multiple regulatory submission pathways
  • Customized analytical strategies for unique product formulations

 

Common Analytical Techniques:
  • HPLC and UPLC for detection of degradants and impurities
  • LC-MS/MS for identification of degradants and impurities
  • GC-MS for volatile compounds and residual solvents
  • Pharmaceutical X-Ray Diffraction (XRD) for material characterization
  • FTIR and micro FTIR for structural characterization
  • Karl Fischer for moisture determination
  • Dissolution testing
  • Ion chromatography
  • Compendial testing (USP, EP, JP)

 

Storage Conditions:
  • Cryogenic freezers (< -130°C)
  • Ultralow temperature (<-60°C)
  • Frozen (-20°C)
  • Refrigerated (2-8°C)
  • Standard ICH conditions: 25°C/60% RH, 30°C/65% RH, 40°C/75% RH
  • Ambient (30°C)
  • Custom conditions based on availability

 

Regulatory Filing Pathway Support:
  • 505(b)(1) Investigational New Drug (IND) application
  • 505(b)(2) New Chemical Entity (NCE) pathway
  • 505(j) Abbreviated New Drug Application (ANDA) for generic drugs
  • NDA (New Drug Application)
  • OTC (Monograph-based or IND-based)

Cutting-edge equipment we use

Our state-of-the-art testing infrastructure includes advanced walk-in and reach-in stability chambers with 24/7 automated monitoring, backup generators ensuring continuous testing capabilities, and specialized instrumentation for comprehensive analysis. Multiple storage condition chambers provide precise environmental control systems, while advanced analytical equipment delivers the characterization depth pharmaceutical development demands.
 
Testing Infrastructure:
  • Advanced stability chambers with 24/7 automated monitoring
  • Backup generators ensuring continuous operation
  • Multiple storage condition chambers with precise environmental control
  • Specialized instrumentation for pharmaceutical analysis
 
Analytical Equipment:
  • Advanced chromatography systems (HPLC, UPLC, GC-MS)
  • Sophisticated spectrophotometry and spectroscopy instrumentation
  • State-of-the-art mass spectrometry, including Quadrupole/Time of Flight tandem mass spectroscopy (Q-TOF)
  • 500 MHz Nuclear Magnetic Resonance (NMR) equipment for structural characterization
  • Dynamic light scattering for specialized applications
  • Specialized analytical tools for pharmaceutical characterization

Which labs offer this service

Element's Ann Arbor, Santa Fe Springs and Toronto laboratories provide ICH-compliant stability storage and testing capabilities. These DEA-licensed, FDA-registered and inspected facilities offer stability-indicating method development and validation alongside controlled substance handling capabilities and comprehensive analytical testing to support your pharmaceutical development programs. 

Integrated Storage and Testing Solutions

Element's laboratories house both stability storage and analytical testing in the same facility, eliminating the coordination challenges that occur when managing separate vendors. Your samples remain under continuous ICH-compliant environmental control from storage pull through analysis, while scientists who understand both environmental parameters and analytical methods can address questions immediately when results require interpretation. Comprehensive stability testing programs generate precise, reliable data across various drug development stages, meeting specific regulatory and scientific requirements for your submissions.

Standards we test to and products we test

These are our most prevalent requests. Don't see what you're looking for? Contact us!
ICH Guidelines

 

Regulatory Standards
  • FDA Regulatory Standards for stability testing
  • USP Compendial Standards
  • EP (European Pharmacopoeia) Standards
  • JP (Japanese Pharmacopoeia) Standards

Your Challenges, Our Solutions

test

Navigating complex regulatory requirements

ICH stability guidelines require comprehensive data packages that demonstrate product quality throughout proposed shelf life. Element's scientific teams design stability programs tailored to your drug substance and product characteristics, generating the specific data regulatory reviewers expect at each submission milestone through phase-appropriate study protocols that address current ICH guideline requirements across multiple storage conditions and timepoints.
test

Ensuring consistent product quality

Comprehensive characterization of impurities, degradants, and critical physicochemical changes provides the analytical foundation for quality control throughout development. Stability testing across multiple conditions reveals how products behave under various environmental stresses, with specialized storage conditions and analytical methods tracking batch-to-batch consistency from early characterization through commercial manufacturing where product specifications must remain within acceptable ranges.
test

Managing specialized testing requirements

Different pharmaceutical products require different analytical approaches and storage conditions based on formulation characteristics and degradation susceptibility. Element provides customized analytical methods and precise storage conditions that account for product-specific sensitivities, covering the specialized requirements various drug products demand throughout stability testing programs designed to meet regulatory expectations.
test

Understanding degradation behavior

Forced degradation studies combined with stability-indicating analytical methods identify impurities, degradants, and physicochemical characteristic changes under multiple stress conditions. This characterization reveals likely degradation pathways, informs formulation decisions, and establishes appropriate specifications that control quality attributes throughout proposed shelf life, providing the analytical foundation regulatory reviewers expect for stability programs.

Why Choose Element

Element scientist in white lab coat working in life sciences testing laboratory

Integrated Storage and Testing

Samples remain under continuous environmental control from storage pull through analysis, eliminating vendor coordination delays and transfer risks.

Multiple North American Locations

FDA-registered and DEA-licensed laboratories in Ann Arbor, Santa Fe Springs, and Toronto provide ICH-compliant stability testing with localized service.

Comprehensive Analytical Capabilities

Advanced methods and instrumentation for pharmaceutical stability testing, forced degradation studies, and photostability evaluation.

Regulatory-Compliant Testing

Stability data generation meeting ICH guideline requirements across multiple regulatory submission pathways.

Frequently asked questions

What regulatory pathways can Element support?

Element supports multiple regulatory pathways including IND applications for clinical investigation, ANDA submissions for generic drugs, and NDA filings for new molecular entities. The stability data generated follows ICH guidelines and addresses Chemistry, Manufacturing, and Controls (CMC) section requirements across these submission types, with testing protocols designed to meet specific reviewer expectations for each pathway.

How do stability-indicating methods differ from standard analytical methods?

Stability-indicating methods are specifically designed and validated to detect and quantify degradation products from the active pharmaceutical ingredient, even when multiple degradants form under stress conditions. Standard analytical methods might detect the API but miss critical impurities that develop during storage. A properly validated stability-indicating method demonstrates specificity for the drug substance in the presence of its degradation products, providing confidence that your analytical data accurately reflects product quality throughout shelf life rather than masking degradation behind unchanged API peaks.

What is forced degradation and why is it important?

Forced degradation involves exposing drug substances to stress conditions like heat, light, oxidation, reducing conditions, acid/base hydrolysis, and agitation to intentionally degrade the molecule and identify potential degradation pathways. This reveals how your product might degrade under real-world conditions, which pathways are most likely, and what degradants to monitor. Understanding degradation behavior early informs several critical decisions: which analytical methods can adequately separate and quantify degradants, what storage conditions protect product quality, which packaging materials prevent degradation, and what specifications appropriately control quality attributes throughout the proposed shelf life.

How does integrated storage and testing benefit my stability program?

Integrated storage and testing within FDA-registered facilities eliminates coordination delays and sample transfer risks that occur when managing separate vendors. Samples remain under continuous ICH-compliant environmental control from storage pull through analysis, while scientists who understand both environmental parameters and analytical methods can address questions immediately when results require interpretation. This integration proves valuable when analytical results raise questions about storage conditions or degradation behavior, as answers come from the same team managing both aspects of your program.  

map

Explore our global network of labs and find your nearest location

VIEW ALL LOCATIONS

Related Resources

Analytical chemist conducting NDSRI testing in pharmaceutical quality control laboratory

NDSRI Testing Regulatory Requirements, Challenges and Timelines Explained

Navigate NDSRI testing complexities including FDA's evolving timeline, why product-specific methods matter, parts-per-billion detection challenges, risk assessment fundamentals, and selecting capable laboratory partners.

Feb 9, 2026

Related services

Pharmaceutical Testing scientific equipment

Analytical Method Development & Validation

Element's regulatory and industry experts have a proven track record of successfully developing and validating fit-for-purpose, accurate, and reliable analytical methods based on established CDER/ICH and FDA guidelines and procedures.

pharmaceutical cmc product development

Chemistry, Manufacturing and Controls (CMC) & CDMO Testing Services

Element provides specialized analytical testing services designed for CDMOs, offering flexible capacity, regulatory compliance, and advanced capabilities that enable successful client program delivery across all development phases.

pharma-qc

Pharmaceutical Quality Control Testing

Element provides pharmaceutical quality control testing, covering raw materials, APIs, and finished products. Our expert analytical development and validation help meet regulatory requirements and support all phases of product development.

Pharmaceutical Testing Extractables and Leachables

Extractables and Leachables Testing Services

Element provides tailored extractables and leachables testing (E&L) studies to ensure patient safety and compliance with regulatory requirements.

Element pharmaceutical testing scientist with laboratory equipment for drug development and compliance

Pharmaceutical Testing Services

Element leads the way in pharmaceutical testing services, delivering trusted expertise from prototype to analysis and finished product. With 150+ global pharmaceutical experts and 30+ years of experience.

Speak to our team of experts

AMERICAS

Toll free from US lines

+1 888 786 7555

EUROPE

Contact our Central Team
UK

Freephone from UK

+44 808 234 1667

Germany

Freephone from Germany 

+49 800 000 5137

MIDDLE EAST

Toll free from UAE

+971 800 353 6368